A detailed history of California State Teachers Retirement System transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 4,975 shares of PSTX stock, worth $15,969. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,975
Previous 4,975 -0.0%
Holding current value
$15,969
Previous $14,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.0 - $3.46 $3,718 - $6,432
-1,859 Reduced 27.2%
4,975 $14,000
Q1 2024

May 15, 2024

SELL
$2.76 - $4.13 $12,014 - $17,977
-4,353 Reduced 38.91%
6,834 $21,000
Q4 2023

Feb 13, 2024

SELL
$1.83 - $3.51 $6,970 - $13,369
-3,809 Reduced 25.4%
11,187 $37,000
Q3 2023

Nov 14, 2023

SELL
$1.62 - $2.79 $12,331 - $21,237
-7,612 Reduced 33.67%
14,996 $35,000
Q2 2023

Aug 21, 2023

SELL
$1.66 - $3.4 $31,222 - $63,950
-18,809 Reduced 45.41%
22,608 $39,000
Q1 2023

May 09, 2023

BUY
$3.08 - $8.73 $127,564 - $361,570
41,417 New
41,417 $127,000
Q2 2022

Aug 15, 2022

SELL
$1.87 - $5.0 $23,156 - $61,915
-12,383 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$3.22 - $7.04 $10,081 - $22,042
-3,131 Reduced 20.18%
12,383 $55,000
Q3 2021

Nov 15, 2021

SELL
$7.09 - $10.71 $171,173 - $258,571
-24,143 Reduced 60.88%
15,514 $113,000
Q2 2021

Aug 16, 2021

SELL
$7.96 - $10.07 $81,868 - $103,569
-10,285 Reduced 20.59%
39,657 $397,000
Q1 2021

May 18, 2021

BUY
$8.51 - $11.91 $252,074 - $352,786
29,621 Added 145.77%
49,942 $477,000
Q3 2020

Nov 17, 2020

BUY
$8.09 - $16.25 $164,396 - $330,216
20,321 New
20,321 $180,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $275M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.